抗性淀粉
现状
2型糖尿病
淀粉
肥胖
医学
生物化学
糖尿病
业务
食品科学
生物技术
生物
内分泌学
政治学
法学
作者
Zhanggui Wang,Shu‐Li Wang,Qinhong Xu,Qi Kong,Fei Li,Lu Lin,Yibiao Xu,Yali Wei
出处
期刊:Advances in Nutrition
[Oxford University Press]
日期:2023-06-03
卷期号:14 (5): 1131-1144
被引量:25
标识
DOI:10.1016/j.advnut.2023.06.001
摘要
Resistant starch (RS) has become a popular topic of research in recent years. Most scholars believe that there are 5 types of RS. However, accumulating evidence indicates that in addition to starch–lipid complexes, which are the fifth type of RS, complexes containing starch and other substances can also be generated. The physicochemical properties and physiologic functions of these complexes are worth exploring. New physiologic functions of several original RSs are constantly being discovered. Research shows that RS can provide health improvements in many patients with chronic diseases, including diabetes and obesity, and even has potential benefits for kidney disease and colorectal cancer. Moreover, RS can alter the short-chain fatty acids and microorganisms in the gut, positively regulating the body’s internal environment. Despite the increase in its market demand, RS production remains limited. Upscaling RS production is thus an urgent requirement. This paper provides detailed insights into the classification, synthesis, and efficacy of RS, serving as a starting point for the future development and applications of RS based on the current status quo.
科研通智能强力驱动
Strongly Powered by AbleSci AI